ExploreInterventionalternate Mediterranean Diet
Intervention

alternate Mediterranean Diet

Also known as: Higher adherence to alternate Mediterranean Diet (aMED), DASH, or Prudent dietary patterns (per 1-SD increase in pre-diagnosis score; aMED from 9 Mediterranean components, DASH from 8 hypertension-related nutrients, Prudent from principal component analysis emphasizing vegetables/fruits/legumes/whole grains/fish)
3 findings 1 paper 3 related entities View in graph →

Related entities

conditions
outcomes
studys

Findings (27)

None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76
None
improvement

Multiple myeloma patients with higher pre-diagnosis aMED, DASH, or Prudent dietary pattern scores had 15-24% lower MM-specific mortality per 1-SD increase, providing convergent evidence that healthier

Effect: improvement; HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent); CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76 to 0.95 (DASH); 95% CI 0.66 to 0.87 (Prude

Size: HR 0.85 (aMED); HR 0.85 (DASH); HR 0.76 (Prudent) CI: 95% CI 0.75 to 0.97 (aMED); 95% CI 0.76

Papers (1)